Financings Of The Fortnight: PIPEing Hot Returns?
This article was originally published in The Pink Sheet Daily
Executive Summary
Novelos Therapeutics and Purdue Pharma's private placement agreement is among notable biotech financings from the past few weeks.
You may also be interested in...
Algeta Recruits Bayer To Deliver Prostate Cancer Drug Alpharadin To Market
Big Pharma still hot for castration-resistant prostate cancer drugs, despite Phase III burns in the past.
Allos' Folotyn and Gloucster's Istodax: Exceptions That Prove The Rule?
ODAC continues to emphasize the importance of randomized controlled trials while supporting approval for two t-cell lymphoma drugs that conducted only singe-arm studies.
For a Look at IPO Future, Follow the Follow-On?
Three recent IPOs have stoked hopes that a broader IPO market may emerge. The market for follow-on public offerings though says more about a potential IPO resurgence than these recent debuts.